Submissions for variant NM_005592.4(MUSK):c.909dup (p.Ala304fs)

dbSNP: rs2131877883

Total submissions: 2

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Revvity Omics, Revvity	RCV001782471	SCV002017822	likely pathogenic	not provided	2021-10-04	criteria provided, single submitter	clinical testing
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard	RCV003225978	SCV003922269	likely pathogenic	Fetal akinesia deformation sequence 1	2023-05-02	criteria provided, single submitter	curation	The heterozygous p.Ala304SerfsTer5 variant in MUSK was identified by our study, in the compound heterozygous state with a variant of uncertain significance (ClinVar Variation ID: 374195), in one individual with fetal akinesia deformation sequence 1. Trio exome analysis revealed that this variant was in trans with a variant of uncertain significance (ClinVar Variation ID: 374195). The p.Ala304SerfsTer5 variant in MUSK has not been previously reported in the literature in individuals with fetal akinesia deformation sequence 1. This variant has also been reported in ClinVar (Variation ID: 1324751) and has been interpreted as likely pathogenic by PerkinElmer Genomics. This variant was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 304 and leads to a premature termination codon 5 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the MUSK gene is an established disease mechanism in autosomal recessive fetal akinesia deformation sequence 1. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive fetal akinesia deformation sequence 1. ACMG/AMP Criteria applied: PVS1, PM2_Supporting (Richards 2015).